Results 201 to 210 of about 67,036 (288)

Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy

open access: yesEuropean Journal of Neurology, Volume 33, Issue 6, June 2026.
In this prospective multicenter study, baseline MRI assessed SVD markers and ICAD severity, showing no graded association between ICAD severity and overall SVD burden, although ICAD was linked to more nonlacunar infarcts and fewer PVS. Over a median 2‐year follow‐up, severe‐to‐occluded ICAD independently increased the risk of ischemic events and ...
Kaori Miwa   +18 more
wiley   +1 more source

Clinical Efficacy of Revascularization Surgery for Moyamoya Angiopathy: Long‐Term Results of a European Cohort

open access: yesEuropean Journal of Neurology, Volume 33, Issue 6, June 2026.
In this European cohort of 276 patients with Moyamoya angiopathy, surgical revascularization, predominantly combined bypass surgery targeting the MCA territory via a mini‐craniotomy, was associated with low perioperative complication rates (6.3%) and stroke rates (2.6%).
Robert Mertens   +10 more
wiley   +1 more source

Differential Influences of Achieved Blood Pressure on Cardiovascular Outcomes by Left Ventricular Geometries According to Chinese Ethnicity‐Specific Echocardiographic Criteria for Hypertensive Patients

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.
ABSTRACT Abnormal LV geometrics implied higher cardiovascular risk for hypertensive patients. Ethnicity‐specific cardiographic criteria classified more accurately the left ventricular (LV) geometric patterns for Chinese than international guideline.
Yicheng Zhu   +9 more
wiley   +1 more source

A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.
ABSTRACT Hypertension is a prevalent and significant risk factor for cardiovascular disease (CVD). The immune system and inflammatory response are involved in the pathophysiology of hypertension. We hypothesize that treating hypertension with colchicine on top of standard therapy, will decrease pulse wave velocity (PWV), left ventricular mass, cardiac ...
Adam Femerling Langhoff   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy